These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 26278617)

  • 1. A successful helium-neon laser and topical tacrolimus combination therapy in one child with vitiligo.
    Byun JW; Babitha S; Kim EK; Shin J
    Dermatol Ther; 2015; 28(6):333-5. PubMed ID: 26278617
    [No Abstract]   [Full Text] [Related]  

  • 2. A preliminary study of fractional CO
    Wen X; Hamblin MR; Xian Y; Li Y
    Dermatol Ther; 2019 Jan; 32(1):e12747. PubMed ID: 30238584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New approach in the treatment of refractory vitiligo: CO
    Cunha PR; Scabine Pessotti N; Bonati Mattos C; Salai AF
    Dermatol Ther; 2017 Jan; 30(1):. PubMed ID: 27548998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicentre, randomized, split face and/or neck comparison of 308-nm excimer laser and 0·1% tacrolimus ointment for stable vitiligo plus intramuscular slow-releasing betamethasone for active vitiligo.
    Wu Y; Sun Y; Qiu L; Wang H; Zhang Y; Chen K; Li H; Gu H; Zhang J; Gao XH
    Br J Dermatol; 2019 Jul; 181(1):210-211. PubMed ID: 30644997
    [No Abstract]   [Full Text] [Related]  

  • 5. Platelet-rich plasma: Potential role in combined therapy for vitiligo.
    Shih S
    Dermatol Ther; 2019 Jan; 32(1):e12773. PubMed ID: 30338878
    [No Abstract]   [Full Text] [Related]  

  • 6. Low-energy helium-neon laser induces locomotion of the immature melanoblasts and promotes melanogenesis of the more differentiated melanoblasts: recapitulation of vitiligo repigmentation in vitro.
    Lan CC; Wu CS; Chiou MH; Hsieh PC; Yu HS
    J Invest Dermatol; 2006 Sep; 126(9):2119-26. PubMed ID: 16691191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triple combination treatment with fractional CO2 laser plus topical betamethasone solution and narrowband ultraviolet B for refractory vitiligo: a prospective, randomized half-body, comparative study.
    Li L; Wu Y; Li L; Sun Y; Qiu L; Gao XH; Chen HD
    Dermatol Ther; 2015; 28(3):131-4. PubMed ID: 25753514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monochromatic excimer light versus combination of topical steroid with vitamin D3 analogue in the treatment of nonsegmental vitiligo: a randomized blinded comparative study.
    Abdel Latif AA; Ibrahim SM
    Dermatol Ther; 2015; 28(6):383-9. PubMed ID: 26358764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study between efficacy of Excimer light with topical Tacrolimus 0.1% versus excimer light with topical Bimatoprost 0.01% in treatment of facial Vitiligo.
    Zaky MS; Atallah RB; El Abasy NTA; Elsaie ML
    Arch Dermatol Res; 2024 Jun; 316(7):350. PubMed ID: 38850408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot comparative study of topical latanoprost and tacrolimus in combination with narrow-band ultraviolet B phototherapy and microneedling for the treatment of nonsegmental vitiligo.
    Korobko IV; Lomonosov KM
    Dermatol Ther; 2016 Nov; 29(6):437-441. PubMed ID: 27329330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helium-neon laser irradiation stimulates migration and proliferation in melanocytes and induces repigmentation in segmental-type vitiligo.
    Yu HS; Wu CS; Yu CL; Kao YH; Chiou MH
    J Invest Dermatol; 2003 Jan; 120(1):56-64. PubMed ID: 12535198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultraviolet light in combination with other therapies for vitiligo: Synergy or necessity?
    Peterson D; King BA
    J Am Acad Dermatol; 2021 Jan; 84(1):e63-e64. PubMed ID: 32891783
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of different types of therapeutic trauma on vitiligo lesions.
    El Mofty M; Esmat S; Hunter N; Mashaly HM; Dorgham D; Shaker O; Ibrahim S
    Dermatol Ther; 2017 Mar; 30(2):. PubMed ID: 27998025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitiligo nonsurgical treatment: a review of latest treatment researches.
    Zhang Y; Mooneyan-Ramchurn JS; Zuo N; Feng Y; Xiao S
    Dermatol Ther; 2014; 27(5):298-303. PubMed ID: 25041437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fractional Carbon Dioxide Laser as an "Add-on" Treatment for Vitiligo: A Meta-analysis with Systematic Review.
    Kim HJ; Hong ES; Cho SH; Lee JD; Kim HS
    Acta Derm Venereol; 2018 Feb; 98(2):180-184. PubMed ID: 29110015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin-1 enhances the proliferation of normal human melanocytes in a paradoxical manner from the TNF-α-inhibited condition, but tacrolimus promotes exclusively the cellular migration without proliferation: a proposed action mechanism for combination therapy of phototherapy and topical tacrolimus in vitiligo treatment.
    Lee KY; Jeon SY; Hong JW; Choi KW; Lee CY; Choi SJ; Kim JH; Song KH; Kim KH
    J Eur Acad Dermatol Venereol; 2013 May; 27(5):609-16. PubMed ID: 22404745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microdermabrasion and topical tacrolimus: A novel combination therapy of vitiligo.
    Abd-Elazim NE; Yassa HA; Mahran AM
    J Cosmet Dermatol; 2020 Jun; 19(6):1447-1455. PubMed ID: 31668003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of microneedling combined with tacrolimus versus either one alone for vitiligo treatment.
    Ebrahim HM; Albalate W
    J Cosmet Dermatol; 2020 Apr; 19(4):855-862. PubMed ID: 32030880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tacrolimus (FK506) ointment combined with Nb-UVB could activate both hair follicle (HF) and dermal melanocyte precursors in vitiligo: the first histopathological and clinical study.
    Gauthier Y; Almasi-Nasrabadi M; Cario-André M; Pain C; Rakhshan A; Ghalamkarpour F
    Arch Dermatol Res; 2021 Jul; 313(5):383-388. PubMed ID: 32303824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of repigmentation induced by photobiomodulation therapy in vitiligo.
    Yu S; Lan CE; Yu HS
    Exp Dermatol; 2019 Feb; 28 Suppl 1():10-14. PubMed ID: 30698884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.